Gender-related changes in the practice and outcomes of percutaneous coronary interventions in Northern New England from 1994 to 1999.
暂无分享,去创建一个
T. Ryan | D. Wennberg | D. Malenka | H. Quinton | M. Watkins | J. Robb | W. Bradley | M. Kellett | S. Shubrooks | B. Hettleman | D. O’Rourke | P. D. Mcgrath | P. Verlee | W. Piper | G. T. O'connor | M. Hearne | Hebe Quinton
[1] J. Ritchie,et al. Comparison of short-term outcomes following coronary artery stenting in men versus women. , 2001, The American journal of cardiology.
[2] S. Shubrooks,et al. Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men. , 2001, The American journal of cardiology.
[3] K. Anstrom,et al. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. , 2001, The American journal of cardiology.
[4] A. Localio,et al. The effects of contemporary use of coronary stents on in-hospital mortality. Registry Committee of the Society for Cardiac Angiography and Interventions. , 2001, Journal of the American College of Cardiology.
[5] The Esprit investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial , 2000, The Lancet.
[6] A. Jacobs,et al. Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries , 2000, Circulation.
[7] A. Kastrati,et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. , 2000, JAMA.
[8] E. Arbustini,et al. Percutaneous transluminal coronary revascularization in women: higher risk of dissection and need for stenting. , 2000, Italian heart journal : official journal of the Italian Federation of Cardiology.
[9] R. Califf,et al. Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome , 2000, Journal of the American College of Cardiology.
[10] B. Gersh,et al. Sex differences in coronary artery size assessed by intravascular ultrasound. , 2000, American heart journal.
[11] K. Anstrom,et al. Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. , 2000, American heart journal.
[12] David Brieger,et al. Textbook of interventional cardiology , 1999 .
[13] T. Ryan,et al. The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. Northern New England Cardiovascular Disease Study Group. , 1999, Journal of the American College of Cardiology.
[14] T. Ryan,et al. Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty. The Northern New England Cardiovascular Disease Study Group. , 1999, American heart journal.
[15] E. Rocha. Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[16] T. Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.
[17] E. Topol. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.
[18] E. Hannan,et al. Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. , 1998, Journal of the American College of Cardiology.
[19] J. Ritchie,et al. Coronary angioplasty outcomes in the Healthcare Cost and Utilization Project, 1993-1994. , 1998, The American journal of cardiology.
[20] T. Ryan,et al. Operator Volume and Outcomes in 12,988 Percutaneous Coronary Interventions , 1998 .
[21] J. Moses,et al. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. , 1997, The American journal of cardiology.
[22] A. Jacobs,et al. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry) , 1997 .
[23] E. DeLong,et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. , 1997, Circulation.
[24] Teirstein Ps. Credentialing for coronary interventions. Practice makes perfect. , 1997 .
[25] T. Ryan,et al. Results of directional coronary atherectomy in Northern New England. Northern New England Cardiovascular Disease Study Group. , 1997, The American journal of cardiology.
[26] E L Hannan,et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. , 1997, JAMA.
[27] L. Chambless,et al. Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states. , 1997, The American journal of cardiology.
[28] D. Wennberg,et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. , 1996, Circulation.
[29] S. Ellis,et al. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. , 1996, The American journal of cardiology.
[30] D. Malenka. Indications, practice, and procedural outcomes of percutaneous transluminal coronary angioplasty in northern New England in the early 1990s. The Northern New England Cardiovascular Disease Study Group. , 1996, The American journal of cardiology.
[31] Russell L. Stogsdill,et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1996, JAMA.
[32] J. Birkmeyer,et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1996, Circulation.
[33] W. O’Neill,et al. Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.
[34] L Pilote,et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.
[35] M. Casper,et al. Race and sex differences in rates of invasive cardiac procedures in US hospitals. Data from the National Hospital Discharge Survey. , 1995, Archives of internal medicine.
[36] S. Ellis,et al. Increased Coronary Perforation in the New Device Era: Incidence, Classification, Management, and Outcome , 1994, Circulation.
[37] C. Simpfendorfer,et al. Gender differences for coronary angioplasty. , 1994, American Journal of Cardiology.
[38] W. Weintraub,et al. Percutaneous transluminal coronary angioplasty in women compared with men. , 1994, Journal of the American College of Cardiology.
[39] L. Shaw,et al. Gender Differences in the Noninvasive Evaluation and Management of Patients with Suspected Coronary Artery Disease , 1994, Annals of Internal Medicine.
[40] D. Malenka,et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1993, Circulation.
[41] K. Bailey,et al. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. , 1993, JAMA.
[42] S. Kelsey,et al. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. , 1993, Circulation.
[43] E. Bolson,et al. Lumen Diameter of Normal Human Coronary Arteries: Influence of Age, Sex, Anatomic Variation, and Left Ventricular Hypertrophy or Dilation , 1992, Circulation.
[44] B. Rutherford,et al. Comparison of procedural results and risks of coronary angioplasty in men and women for conditions other than acute myocardial infarction. , 1992, The American journal of cardiology.
[45] W. Weaver,et al. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. , 1992, Archives of internal medicine.
[46] E. Topol,et al. Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings. , 1991, The American journal of cardiology.
[47] J. Althoff. Sex differences in the management of coronary artery disease: Steingart RM, Packer M, Hamm P, et al N Engl J Med 325: 226–230 Jul 1991 , 1991 .
[48] J Z Ayanian,et al. Differences in the use of procedures between women and men hospitalized for coronary heart disease. , 1991, The New England journal of medicine.
[49] Huang Teh-Yang,et al. Radiation exposure of pediatric patients and physicians during cardiac catheterization and balloon pulmonary valvuloplasty , 1991 .
[50] C. Simpfendorfer,et al. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women. , 1987, Catheterization and cardiovascular diagnosis.
[51] J. Buring,et al. Epidemiology in Medicine , 1987 .
[52] W. Baumgartner,et al. Coronary Artery Bypass Grafting in Women A Ten‐year Perspective , 1985, Annals of surgery.
[53] H. Morgenstern,et al. Epidemiologic Research: Principles and Quantitative Methods. , 1983 .
[54] J. L. Martin,et al. Cardiac metastasis from uterine leiomyosarcoma. , 1983, Journal of the American College of Cardiology.
[55] W. C. Sheldon,et al. Coronary artery surgery in women compared with men: analyses of risks and long-term results. , 1983, Journal of the American College of Cardiology.
[56] B. Brodie,et al. Influence of vessel size on early and late outcomes after primary angioplasty for acute myocardial infarction. , 2000, The Journal of invasive cardiology.
[57] M. Codd,et al. Gender differences in the treatment and outcome of acute myocardial infarction , 1998 .
[58] M. Bell,et al. Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women. , 1997, Mayo Clinic proceedings.
[59] W. O’Neill,et al. Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.
[60] D. Wennberg,et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. , 1996, Circulation.
[61] J. Muller,et al. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. , 1994, Journal of the American College of Cardiology.
[62] J. Muller,et al. Similar result of percutaneous transluminal coronary angioplasty for women and men with postmyocaedial infarction ischemia , 1994 .
[63] S. Kelsey,et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. , 1985, Circulation.